3 Results for "

aggregation lag phase

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "aggregation lag phase" in MCE Product Catalog:

  • Targets Recommended:
Cat. No.: HY-157700
CAS No.: 97802-53-4
Synonyms: C16(Plasm) LPC; Lysophosphatidylcholine 16:0p/0:0
Research Areas:  

Neurological Disease

Hexadecenyl-2-hydroxy-sn-glycero-3-PC (C16(Plasm) LPC) is a phosphatidylcholine. Hexadecenyl-2-hydroxy-sn-glycero-3-PC prolongs the lag-phase of α-syn aggregation, and can be used in Parkinson’s disease research .
loading...
    loading...
Cat. No.: HY-184819
CAS No.: 2883627-56-1
α-Synuclein-IN-24 is an α-synuclein (α-Syn) aggregation inhibitor with an IC50 of 4.0 μM. α-Synuclein-IN-24 stabilizes the secondary conformation of α-synuclein monomers, inhibits β-sheet formation, reduces oligonucleation during the aggregation lag phase, dissociates preformed aggregates, and blocks reaggregation. α-Synuclein-IN-24 reduces α-synuclein inclusions in neuronal cells and scavenges ROS. α-Synuclein-IN-24 can be used for the research of Parkinson's disease .
loading...
    loading...
Cat. No.: HY-184816
CAS No.: 2883627-65-2
α-Synuclein-IN-21 is an α-synuclein (α-Syn) aggregation inhibitor with an IC50 of 1.6 μM. α-Synuclein-IN-21 stabilizes the secondary conformation of α-synuclein monomers, inhibits β-sheet formation, reduces oligonucleation during the aggregation lag phase, dissociates preformed aggregates, and blocks re-aggregation. α-Synuclein-IN-21 reduces α-synuclein inclusions in neuronal cells and scavenges ROS. α-Synuclein-IN-21 can be used for the research of Parkinson's disease .
loading...
    loading...